Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussion highlights specific pharmacokinetic details, such as the fast half-life at low doses, showing modest curiosity and basic engagement, with no strong reactions or calls to action, reflecting a neutral overall response to the publication.
The only comment made acknowledges the question but doesn't express strong support or disagreement with the publication.
The discussion indicates some curiosity about pharmacokinetics but doesn't show deep engagement or enthusiasm.
The post mentions specific details like half-life and dosage but remains at a moderate level of detail without extensive discussion.
The exchange offers informational value but does not suggest a significant influence or transformative impact stemming from the publication.
@HLcure2020 @hubermanlab @DrBevinBhoyrul Good question. Dutasteride has linear and non linear pharmacokinetics (similar to acetaminophen). At a dose of 0.01mg a day, half life so fast it’s below LCMS quant limit after 30mins. 0.1mg: hours. 0.5mg: days. https://t.co/Xs7kQBpQun
RT @GillettHealth: @HLcure2020 @hubermanlab @DrBevinBhoyrul Good question. Dutasteride has linear and non linear pharmacokinetics (similar…
This video discusses the recommended dosing practices for finasteride and dutasteride in treating hair loss, emphasizing pharmacokinetics and clinical considerations to optimize efficacy and safety.
This video explores whether low doses of dutasteride can effectively treat hair loss with fewer side effects, based on clinical studies and pharmacokinetic models.
This video explains how to transition from finasteride to dutasteride and discusses how long dutasteride takes to show effects, based on pharmacokinetic modelling and clinical principles.
This video discusses a clinical trial evaluating the safety and effectiveness of 0.2 mg low-dose Dutasteride in treating male androgenic alopecia, highlighting its potential as an undervalued treatment option.
Join the channel Discord for discussions on hair loss theories and experiences. This video explores clinical literature on Dutasteride, including pharmacokinetics, effects on scalp DHT, and specific dosing strategies…
This video explores the efficacy and safety of different doses of dutasteride compared to placebo and finasteride in treating male pattern hair loss, emphasizing the importance of dual 5-reductase inhibition for…
RT @GillettHealth: @HLcure2020 @hubermanlab @DrBevinBhoyrul Good question. Dutasteride has linear and non linear pharmacokinetics (similar…
RT @GillettHealth: @HLcure2020 @hubermanlab @DrBevinBhoyrul Good question. Dutasteride has linear and non linear pharmacokinetics (similar…
@HLcure2020 @hubermanlab @DrBevinBhoyrul Good question. Dutasteride has linear and non linear pharmacokinetics (similar to acetaminophen). At a dose of 0.01mg a day, half life so fast it’s below LCMS quant limit after 30mins. 0.1mg: hours. 0.5mg: days. https://t.co/Xs7kQBpQun